Clinical Trial Update: A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating protective efficacy of three doses of oral rotavirus vaccine ORV 116E for rotavirus gastroenteritis; current status is UNKNO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Oral Rotavirus Vaccine 116E (rotavirus vaccine (live, oral))

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Viral Gastroenteritis Due to Rotavirus | Phase 3 | Status: UNKNOWN